T7 phage display of Ep15 peptide for the detection of WNV IgG

Journal of Virological Methods

Volumn 141, Issue 2, 2007, Pages 133-140

  Herrmann, Sebastien ^a   Leshem, Boaz ^a   Lobel, Leslie ^a   Bin, Hannah ^b   Mendelson, Ella ^b   Ben Nathan, David ^c   Dussart, Philippe ^d   Porgador, Angel ^a   Rager Zisman, Bracha ^a   Marks, Robert S ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^d Centre National de Reference des Arbovirus Cayenne   (French Guiana)

Author keywords

ELISA; Ep15; Phage display; T7 bacteriophage; West Nile virus

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; MACROGOL; PEPTIDE; PROTEIN EP15; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; BACTERIOPHAGE T7; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLAVIVIRUS; HUMAN; MOLECULAR CLONING; NONHUMAN; NORTH AMERICA; PHAGE DISPLAY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ANTIBODIES, VIRAL; BACTERIOPHAGE T7; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; IMMUNOGLOBULIN G; PEPTIDE LIBRARY; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; VIRAL PROTEINS; WEST NILE FEVER; WEST NILE VIRUS;

FLAVIVIRUS; WEST NILE VIRUS;

EID: 33947509960     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.11.041     Document Type: Article

References (31)

1. Beasley D.W., and Barrett A.D. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J. Virol. 76 (2002) 13097-13100
2. Ben-Nathan D., Lustig S., Tam G., Robinzon S., Segal S., and Rager-Zisman B. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J. Infect. Dis. 188 (2003) 5-12
3. Castillo J., Goodson B., and Winter J. T7 displayed peptides as targets for selecting peptide specific scFvs from M13 scFv display libraries. J. Immunol. Meth. 257 (2001) 117-122
4. Chu J.J., Rajamanonmani R., Li J., Bhuvanakantham R., Lescar J., and Ng M.L. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J. Gen. Virol. 86 (2005) 405-412
5. Davis B.S., Chang G.J., Cropp B., Roehrig J.T., Martin D.A., Mitchell C.J., Bowen R., and Bunning M.L. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 75 (2001) 4040-4047
6. Enserink M. Infectious disease. West Nile's surprisingly swift continental sweep. Science 297 (2002) 1988-1989
7. Feinstein S., Akov Y., Lachmi B.E., Lehrer S., Rannon L., and Katz D. Determination of human IgG and IgM class antibodies to West Nile virus by enzyme linked immunosorbent assay (ELISA). J. Med. Virol. 17 (1985) 63-72
8. Fernandez-Escamilla A.M., Rousseau F., Schymkowitz J., and Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 22 (2004) 1302-1306
9. Hayes E.B., Komar N., Nasci R.S., Montgomery S.P., O'Leary D.R., and Campbell G.L. Epidemiology and transmission dynamics of West Nile virus disease. Emerg. Infect. Dis. 11 (2005) 1167-1173
10. Herrmann S., Leshem B., Landes S., Rager-Zisman B., and Marks R.S. Chemiluminescent optical fiber immunosensor for the detection of anti-West Nile virus IgG. Talanta 66 (2005) 6-14
11. Higgs S., Schneider B.S., Vanlandingham D.L., Klingler K.A., and Gould E.A. Nonviremic transmission of West Nile virus. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8871-8874
12. Hogrefe W.R., Moore R., Lape-Nixon M., Wagner M., and Prince H.E. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. J. Clin. Microbiol. 42 (2004) 4641-4648
13. Lanciotti R.S., Ebel G.D., Deubel V., Kerst A.J., Murri S., Meyer R., Bowen M., McKinney N., Morrill W.E., Crabtree M.B., Kramer L.D., and Roehrig J.T. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 298 (2002) 96-105
14. Lanciotti R.S., Roehrig J.T., Deubel V., Smith J., Parker M., Steele K., Crise B., Volpe K.E., Crabtree M.B., Scherret J.H., Hall R.A., MacKenzie J.S., Cropp C.B., Panigrahy B., Ostlund E., Schmitt B., Malkinson M., Banet C., Weissman J., Komar N., Savage H.M., Stone W., McNamara T., and Gubler D.J. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286 (1999) 2333-2337
15. Lehmann D., Sodoyer R., and Leterme S. Characterization of BoHV-1 gE envelope glycoprotein mimotopes obtained by phage display. Vet. Microbiol. 104 (2004) 1-17
16. Li L., Barrett A.D., and Beasley D.W. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains. Virology 335 (2005) 99-105
17. Mackenzie J.S., Gubler D.J., and Petersen L.R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10 (2004) S98-S109
18. Muerhoff A.S., Dawson G.J., Dille B., Gutierrez R., Leary T.P., Gupta M.C., Kyrk C.R., Kapoor H., Clark P., Schochetman G., and Desai S.M. Enzyme-linked immunosorbent assays using recombinant envelope protein expressed in COS-1 and Drosophila S2 cells for detection of West Nile virus immunoglobulin M in serum or cerebrospinal fluid. Clin. Diagn. Lab. Immunol. 11 (2004) 651-657
19. Nybakken G.E., Oliphant T., Johnson S., Burke S., Diamond M.S., and Fremont D.H. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437 (2005) 764-769
20. O'Connor K.H., Konigs C., Rowley M.J., Irving J.A., Wijeyewickrema L.C., Pustowka A., Dietrich U., and Mackay I.R. Requirement of multiple phage displayed peptide libraries for optimal mapping of a conformational antibody epitope on CCR5. J. Immunol. Meth. 299 (2005) 21-35
21. Petersen L.R., and Roehrig J.T. West Nile virus: a reemerging global pathogen. Emerg. Infect. Dis. 7 (2001) 611-614
22. Prince H.E., and Lape-Nixon M. Evaluation of a West Nile virus immunoglobulin A capture enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 12 (2005) 231-233
23. Rosenberg A.H., Griffin K., Washington M.T., Patel S.S., and Studier F.W. Selection, identification, and genetic analysis of random mutants in the cloned primase/helicase gene of bacteriophage T7. J. Biol. Chem. 271 (1996) 26819-26824
24. Saha S., Bhasin M., and Raghava G.P. Bcipep: a database of B-cell epitopes. BMC Genomics 6 (2005) 79
25. Smithburn K., Hughes T., Burke A., and Paul J. A neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop. Med. Hyg. 20 (1940) 471-492
26. Tran A., Deparis X., Dussart P., Morvan J., Rabarison P., Remy F., Polidori L., and Gardon J. Dengue spatial and temporal patterns, French Guiana, 2001. Emerg. Infect. Dis. 10 (2004) 615-621
27. Uchiyama F., Tanaka Y., Minari Y., and Tokui N. Designing scaffolds of peptides for phage display libraries. J. Biosci. Bioeng. 99 (2005) 448-456
28. Vijayasri S., and Agrawal S. Domain-based homology modeling and mapping of the conformational epitopes of envelope glycoprotein of west nile virus. J. Mol. Model (Online) 11 (2005) 248-255
29. Volk D.E., Beasley D.W., Kallick D.A., Holbrook M.R., Barrett A.D., and Gorenstein D.G. Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J. Biol. Chem. 279 (2004) 38755-38761
30. Wang L.F., and Yu M. Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Curr. Drug Targets 5 (2004) 1-15
31. Wong S.J., Boyle R.H., Demarest V.L., Woodmansee A.N., Kramer L.D., Li H., Drebot M., Koski R.A., Fikrig E., Martin D.A., and Shi P.Y. Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from Dengue and St. Louis Encephalitis virus infections and from Flavivirus vaccination. J. Clin. Microbiol. 41 (2003) 4217-4223